I invented * Marijuana Chew * for the benefit of peace throughout my body; physical, mental and spiritual which begat no pain but recreation (simple walking and bending). I Invented * Marijuana Chew * to help me get off of the severe medications that I was on from my tenure at the WTC since Sep. 11, 2001 and from my inherited illnesses thence, while serving my community.

I began this invention slowly (under my state's license) and while it has morphed to an infused aspect now, incorporating my knowledge of certain herbs and spices and their traits and qualities in addition to the superb marijuana plant's dynamics, the flavors neutralize the pungency of the natural plant and fight inflammation; at least.

So, I bring you, “* Marijuana Chew * with natural.

While it's not the answer to everything. It can certainly allow you to breathe, move and live comfortably; enjoy responsibly.

Disclosed are means, methods and compositions of matter useful for treatment of lung inflammation associated with viral and bacterial infections, as well as with systemic inflammation, through administration of umbilical cord blood derived plasma-based compositions. In one embodiment the invention teaches administration of umbilical cord blood plasma together with pterostilbene, and/or sulforaphane, and/or thymoquinone, and/or Epigallocatechin gallate (EGCG) and/or n-acetylcysteine in an aerosolized manner to patients suffering from COVID-19 associated pulmonary deficiencies. In another embodiment, umbilical cord blood plasma is administered with immune stimulatory agents in order to concurrently inhibit propagation of viral load in the lung while suppressing pulmonary deficiencies.

Disclosed are means, methods and compositions of matter useful for treatment of lung inflammation associated with viral and bacterial infections, as well as with systemic inflammation, through administration of umbilical cord blood derived plasma-based compositions. In one embodiment the invention teaches administration of umbilical cord blood plasma together with pterostilbene, and/or sulforaphane, and/or thymoquinone, and/or Epigallocatechin gallate (EGCG) and/or n-acetylcysteine in an aerosolized manner to patients suffering from COVID-19 associated pulmonary deficiencies. In another embodiment, umbilical cord blood plasma is administered with immune stimulatory agents in order to concurrently inhibit propagation of viral load in the lung while suppressing pulmonary deficiencies.

A method for treating the gastro-intestinal or a urogenital system of a subject with prebiotic nutrients and probiotic bacteria is provided. Multi-chamber products are described which include at least two chambers wherein probiotic bacteria or human microbiome transplants are contained in one or more inner chambers and wherein prebiotic nutrients are contained in an outer chamber, the outer chamber completely enclosing the inner chamber(s). One or both chambers may contain a pharmaceutically acceptable material that is solid outside the human body when in a dry environment, but that melts at internal body temperature. The products may be administered by oral, rectal, vaginal, or urethral routes.

A method for treating the gastro-intestinal or a urogenital system of a subject with prebiotic nutrients and probiotic bacteria is provided. Multi-chamber products are described which include at least two chambers wherein probiotic bacteria or human microbiome transplants are contained in one or more inner chambers and wherein prebiotic nutrients are contained in an outer chamber, the outer chamber completely enclosing the inner chamber(s). One or both chambers may contain a pharmaceutically acceptable material that is solid outside the human body when in a dry environment, but that melts at internal body temperature. The products may be administered by oral, rectal, vaginal, or urethral routes.

The present invention relates to a composition for oral use comprising at least an extract of red yeast rice, at least an extract of a plant belonging to the genus Allium and at least an extract of a plant belonging to the genus Malus and to the use thereof for the prevention and/or treatment of hypercholesterolemia, the main cardiovascular risk factor.

The present invention relates to a composition for oral use comprising at least an extract of red yeast rice, at least an extract of a plant belonging to the genus Allium and at least an extract of a plant belonging to the genus Malus and to the use thereof for the prevention and/or treatment of hypercholesterolemia, the main cardiovascular risk factor.

The present invention relates to a composition for oral use comprising at least an extract of red yeast rice, at least an extract of a plant belonging to the genus Allium and at least an extract of a plant belonging to the genus Malus and to the use thereof for the prevention and/or treatment of hypercholesterolemia, the main cardiovascular risk factor.

The present invention relates to: an Agrimonia eupatoria extract preparation method for promoting the recovery rate and bioavailability of an active ingredient; and a composition for improving liver functions or treating liver diseases, containing the extract. More specifically, the present invention provides an Agrimonia eupatoria extract preparation method capable of extracting Agrimonia eupatoria by using a solvent in which cyclodextrin is dissolved, thereby increasing the recovery rate and bioavailability of an active ingredient, and provides a health functional food for improving liver functions or an agent for treating liver diseases, the food and the agent containing an Agrimonia eupatoria extract and having enhanced efficacy.

The present invention relates to: an Agrimonia eupatoria extract preparation method for promoting the recovery rate and bioavailability of an active ingredient; and a composition for improving liver functions or treating liver diseases, containing the extract. More specifically, the present invention provides an Agrimonia eupatoria extract preparation method capable of extracting Agrimonia eupatoria by using a solvent in which cyclodextrin is dissolved, thereby increasing the recovery rate and bioavailability of an active ingredient, and provides a health functional food for improving liver functions or an agent for treating liver diseases, the food and the agent containing an Agrimonia eupatoria extract and having enhanced efficacy.